RxDoctor Payments Data

Melinda Stoner, PA

Medical · Thomas, WVNPI 1093841249

Payments from drug & device makers

$954in general payments, 2019–2025

Across 56 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$220
  • AstraZeneca$190
  • Lilly USA, LLC$116
  • AbbVie$109
  • Exact Sciences$75
  • Boehringer Ingelheim$68
  • plus $176 from 7 others

What the payments were for

  • Food & beverage$954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$954 in reported general payments places this provider in the 55th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia

Medicare billing

Part B allowed, 2024
$21,659
Medicare patients
115
Services billed
349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin38$43,007
OzempicSemaglutide26$38,797
EliquisApixaban46$38,371
Tresiba Flextouch U-200Insulin Degludec16$33,555
MounjaroTirzepatide19$19,834
XareltoRivaroxaban14$16,446
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$11,052
Praluent PenAlirocumab11$6,593
Breo ElliptaFluticasone/Vilanterol12$6,348
Tresiba Flextouch U-100Insulin Degludec11$6,256
Losartan Potassium120$1,925
Metoprolol Succinate85$1,895
Atorvastatin Calcium126$1,685
Ultra-Fine Short Pen NeedlePen Needle, Diabetic18$1,608
Potassium Chloride46$1,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$68$43,00738 claims
Novo NordiskOzempic$220$38,79726 claims
PfizerEliquis$17$38,37146 claims
Lilly USA, LLCMounjaro$116$19,83419 claims
GSKTrelegy Ellipta, Breo Ellipta$32$17,39925 claims
AbbVieSynthroid$109$1,26221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 233 medical providers in West Virginia.

Other medical in Thomas

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →